TABLE OF CONTENTS
Volume 33, Issue 2 (January (2) 2004)
Conditioning Regimens |
CD34+ Cell Dose |
HLA Typing |
Hematopoietic Growth Factors |
Acute Myeloid Leukemia |
Infections Post-Transplant |
Veno-Occlusive Disease of Liver |
Viral Infections |
Growth Post Transplant |
Chimerism |
Normal Donors |
Relapse of Leukemia |
Case report |
Correspondence
Mini Review
Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know
H L Leather
Bone Marrow Transplant 33: 137-152; advance online publication, December 15, 2003; doi:10.1038/sj.bmt.1704316
Conditioning Regimens
Toward a myeloablative regimen with clinical potential: II. Treosulfan induces specific skin graft tolerance across haploidentical MHC barriers
M van Pel, D W J G van Breugel, W Vos, R E Ploemacher and C J P Boog
Bone Marrow Transplant 33: 153-159; advance online publication, December 8, 2003; doi:10.1038/sj.bmt.1704333
CD34+ Cell Dose
Ideal or actual body weight to calculate CD34+ cell doses for allogeneic hematopoietic stem cell transplantation?
J Cilley, C Rihn, J Monreal, L I Gordon, S Singhal, M Tallman, S Williams, J Winter and J Mehta
Bone Marrow Transplant 33: 161-164; advance online publication, December 1, 2003; doi:10.1038/sj.bmt.1704388
HLA Typing
HistoCheck: rating of HLA class I and II mismatches by an internet-based software tool
H-A Elsner, D DeLuca, J Strub and R Blasczyk
Bone Marrow Transplant 33: 165-169; advance online publication, December 1, 2003; doi:10.1038/sj.bmt.1704301
Hematopoietic Growth Factors
Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors
P Topcuoglu, M Arat, K Dalva and M Özcan
Bone Marrow Transplant 33: 171-176; advance online publication, December 1, 2003; doi:10.1038/sj.bmt.1704341
Acute Myeloid Leukemia
Autologous stem cell transplantation for acute myelogenous leukemia in first complete remission: a 6-year follow-up study of 101 patients from a single institution
N Vey, R Bouabdallah, A Stoppa, C Faucher, M Lafage, C Chabannon, D Sainty, J Gastaut, D Maraninchi and D Blaise
Bone Marrow Transplant 33: 177-182; advance online publication, November 24, 2003; doi:10.1038/sj.bmt.1704326
Infections Post-Transplant
Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation
J A Pérez-Simón, I García-Escobar, J Martinez, L Vazquez, D Caballero, C Cañizo, M V Mateos and J F San Miguel
Bone Marrow Transplant 33: 183-187; advance online publication, December 1, 2003; doi:10.1038/sj.bmt.1704335
Veno-Occlusive Disease of Liver
Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention
S Corbacioglu, J Greil, C Peters, N Wulffraat, H J Laws, D Dilloo, B Strahm, U Gross-Wieltsch, K W Sykora, A Ridolfi-Lüthy, O Basu, B Gruhn, T Güngör, W Mihatsch and A S Schulz
Bone Marrow Transplant 33: 189-195; advance online publication, December 8, 2003; doi:10.1038/sj.bmt.1704329
Viral Infections
Influence of cytomegalovirus (CMV) sero-positivity on CMV infection, lymphocyte recovery and non-CMV infections following T-cell-depleted allogeneic stem cell transplantation: a comparison between two T-cell depletion regimens
S Chakrabarti, D W Milligan, J Brown, H Osman, I B Vipond, D H Pamphilon and D I Marks
Bone Marrow Transplant 33: 197-204; advance online publication, December 1, 2003; doi:10.1038/sj.bmt.1704334
Growth Post Transplant
Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia
P Frisk, J Arvidson, J Gustafsson and G Lönnerholm
Bone Marrow Transplant 33: 205-210; advance online publication, November 17, 2003; doi:10.1038/sj.bmt.1704324
Chimerism
Prompt initiation of immunotherapy in children with an increasing number of autologous cells after allogeneic HCT can induce complete donor-type chimerism: a report of 14 children
E Gorczyñska, D Turkiewicz, J Toporski, K Kalwak, B Rybka, R Ryczan, L Sajewicz and A Chybicka
Bone Marrow Transplant 33: 211-217; advance online publication, November 17, 2003; doi:10.1038/sj.bmt.1704321
Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia
W Hoelle, J F Beck, G Dueckers, H Kreyenberg, P Lang, B Gruhn, M Führer, D Niethammer, T Klingebiel and P Bader
Bone Marrow Transplant 33: 219-223; advance online publication, December 1, 2003; doi:10.1038/sj.bmt.1704337
Normal Donors
Donor commitment and patient needs
R Bakken, A-M van Walraven and T Egeland for the Ethics Working Group of the World Marrow Donor Association
Bone Marrow Transplant 33: 225-230; advance online publication, November 17, 2003; doi:10.1038/sj.bmt.1704323
Relapse of Leukemia
A pilot study of cytoreductive chemotherapy combined with infusion of additional peripheral blood stem cells reserved at time of harvest for transplantation in case of relapsed hematologic malignancies after allogeneic peripheral blood stem cell transplant
J G Kim, S K Sohn, D H Kim, N Y Lee, J S Suh, K S Lee and K B Lee
Bone Marrow Transplant 33: 231-236; advance online publication, December 1, 2003; doi:10.1038/sj.bmt.1704328
Cytogenetic clonal evolution alone in CML relapse post-transplantation does not adversely affect response to imatinib mesylate treatment
Y-J Kim, D-W Kim, S Lee, Y-L Kim, J-Y Hwang, Y-H Park, H-J Kim, J-W Lee, W-S Min and C-C Kim
Bone Marrow Transplant 33: 237-242; advance online publication, November 17, 2003; doi:10.1038/sj.bmt.1704332
Case report
Late cytomegalovirus polyradiculopathy following haploidentical CD34+-selected hematopoietic stem cell transplantation
R Zeiser, C Grüllich, H Bertz, G Pantazis, F T Hufert, T A Bley and J Finke
Bone Marrow Transplant 33: 243-245; doi:10.1038/sj.bmt.1704311
Correspondence
Secondary Philadelphia chromosome after non-myeloablative peripheral blood stem cell transplantation for a myelodysplastic syndrome in transformation
T Prebet, A-S Michallet, C Charrin, S Hayette, J-P Magaud, A Thiébaut, M Michallet and F E Nicolini
Bone Marrow Transplant 33: 247-249; doi:10.1038/sj.bmt.1704308
Nonmyeloablative allogenic peripheral-blood stem-cell transplantation in pancreatic adenocarcinoma: one case, high expectations
L Laghi, L Castagna and A Malesci
Bone Marrow Transplant 33: 251; advance online publication, December 1, 2003; doi:10.1038/sj.bmt.1704331
Successful reduced-intensity HLA-haploidentical stem cell transplantation based on the concept of feto-maternal tolerance for an elderly patient with myelodysplastic syndrome
K Obama, Y Takemoto, Y Takatsuka and A Utsunomiya
Bone Marrow Transplant 33: 253; advance online publication, November 24, 2003; doi:10.1038/sj.bmt.1704350
Urgent need for a validated tumor response evaluation system for use in immunotherapy
A Hori, M Kami, S-W Kim, N Murashige, M Sakiyama, R Kojima, T Hamaki, A Makimoto, S Miyakoshi, S Masuo, S Taniguchi, H Kunitoh and Y Takaue
Bone Marrow Transplant 33: 255-256; advance online publication, December 15, 2003; doi:10.1038/sj.bmt.1704371